NOI-Service and Maintenance of our BD Fortessa Flo

The National Institutes of Health, Office of the Director, Office of Acquisitions, is issuing a non-competitive combined synopsis/solicitation under FAR 12.603 to award a firm fixed-price service contract to Becton, Dickinson, and Company for the maintenance and repair of BD Fortessa Flow Cytometry equipment used in the Laboratory of Molecular Immunology. This acquisition, identified by solicitation number 75N98026Q00576/PCA-NIAID-04688, does not require full and open competition and is authorized under FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901, as it falls below the simplified acquisition threshold and involves a sole-source arrangement for specialized commercial services. The contract period extends from July 10, 2026, to July 9, 2027, with performance occurring at the Laboratory of Molecular Immunology in Bethesda, Maryland. The scope of work includes emergency and preventative maintenance, requiring OEM factory-trained and authorized technicians to perform one annual inspection of approximately two hours and provide replacement parts, labor, and travel for urgent repairs, excluding consumables. All parts, software, and diagnostic tools must be OEM-certified and fully compatible with the equipment, with access to proprietary instrumentation and documentation required for effective service delivery. Responses must be submitted by June 19, 2026, at 4:00 p.m. EDT, and must include a completed FAR 52.212-3 form, a Unique Entity Identifier, a Taxpayer Identification Number, proof of active SAM registration, and a detailed price quotation containing unit and list prices, shipping and handling costs, delivery timeframe, delivery terms, prompt payment discounts, F.O.B. point, and product catalog numbers. The government will not reimburse travel or per diem for regular on-site service, and contractors must comply with Section 508 of the Rehabilitation Act. Although no specific evaluation weights are provided, the award will be determined using FAR 52.212-2, considering factors such as past performance, technical capability, warranty, maintenance availability, and lifecycle expectations. The contracting officer has determined no additional terms beyond standard commercial practices and FAR 52.212-4, FAR 52.212-5, FAR 52.217-8, and HHSAR